F O C U S Genzyme reports significant revenue and earnings growth in 1Q 2007 Genzyme Corp reported that 1Q 2007 revenue increased 21% to a record $883.2 M ($730.8 M in 1Q 2006). GAAP net income rose 57% for 1Q 2007 to $158.2 M ($101 M in 1Q 2006), reflecting higher revenue, an improved gross margin, and continued expense control. GAAP earnings for 1Q 2007 rose 54% to $0.57/diluted share, up from $0.37 in 1Q 2006. Non-GAAP net income for 1Q 2007 grew 35% to $210.7 M ($156.5 M in 1Q 2006). Non-GAAP earnings grew 33% to $0.78/diluted share, for 1Q 2007 ($0.59 in 1Q 2006). Genzyme 1Q 2007 results, 25 Apr 2007 (Genzyme Corp, One Kendall Square, Cambridge, MA 02139, USA. Tel: +1 617 252 7500. Fax: +1 617 252 7600. Website: http://www.genzyme.com)
Grace 1Q 2007: core operations Grace Davison
O N
C ATA LY S T S
Novozymes opens Midwest location As industrial and national interest in ethanol-based fuel research and production continues to increase, Novozymes has established a Midwest Customer Solutions Center in Ames, Iowa, in order to better serve its customer base in the Biofuels Industry. The Center, located at the Iowa State University Research Park, will provide regionalized support and technical service to customers beginning in Apr 2007. Customer training programs will be implemented upon the building’s completion, expected in Jul 2007. The focus of the site will be to provide regionally-based know-how and services to Novozymes’ customer base in the Midwest, with an emphasis on support and training to plants using enzyme products to convert starches into fuel ethanol. Biomass Initiative, Apr 2007 (US Dept of Energy, Office of Energy Efficiency and Renewable Energy. Website: http://www.bioproducts-bioenergy.gov)
1Q 2007 sales for the Grace Davison operating segment, which includes silica- and alumina-based catalysts and materials used in a wide range of industrial applications, were $387.7 M, up 8.8% from the prior year quarter. The primary factors contributing to the sales increase were: (1) selling price increases implemented to partially offset cost inflation of certain commodity raw materials; (2) higher volume of fluid cracking catalysts in most geographic regions from stronger economic activity and from the success of strategic growth initiatives; and (3) favourable translation effects from sales denominated in foreign currencies. Sales of hydroprocessing refining catalysts were lower in the first quarter of 2007 due to the timing of customer refill orders for processing units commissioned in 2006 in response to low sulfur fuel regulations in the US. Pre-tax operating income of the Grace Davison operating segment for 1Q 2007 was $45.0 M compared with $36.0 M in the prior year quarter, a 25.0% increase. Operating margin was 11.6%, compared with 10.1% in the prior year quarter.
Novozymes launches enzyme Ultraflo Max for brewing industry
Grace reports first quarter financial results 2007, 25 Apr 2007, 2 (WR Grace & Co, 7500 Grace Drive, Columbia, MD 21044, USA. Website: http://www.grace.com)
Oxonica has problems with Envirox
4
Novozymes is launching the enzyme Ultraflo Max for beer filtration in the brewing industry. Ultraflo Max offers increased capacity and lower costs regardless what type of malt is used and presents Novozymes with the possibility for expanding the market for brewing enzymes. It allows the industry to deal with problems stemming from reduced supply of malt and poor malt quality. Net Posten, 7 May 2007 (Website: http://www.netposten.dk/) (in Danish)
Novozymes to set up R&D facility in Bangalore In tune with the growing market for its enzymes and micro-organisms business, Novozymes is on the way to setting up an R&D laboratory and office in Bangalore, India. The centre will mainly work on optimising enzyme properties. The R&D centre will allow Novozymes to make use of the skilled work force and academic environment available in the country. Chemical Weekly, 20 Mar 2007, 52 (31), 134
Oxonica’s share price has fallen in response to problems with Envirox.
First it was involved in a disagreement over the ownership of the intellectual property for the fuel catalyst product. Following that, the company revealed that the trials for the product for Turkish company Petrol Ofisi were inconclusive and disappointing. Nanotech Report (Forbes/Wolfe), Apr 2007, 6 (4), 8 (Website: http://www.forbesnanotech.com)
PQ to be acquired by private equity group PQ (formerly Philadelphia Quartz, a manufacturer of silica compounds and catalysts) is to be acquired by The Carlyle Group for about $1.5 bn, subject to approvals from regulatory authorities. Chemical Week, 30 May 2007, 169 (19), 4
SCR-Tech announces SCR catalyst regeneration orders totalling $1.0 M Catalytica Energy Systems Co’s subsidiary SCR-Tech has secured new contracts totalling some $1.0 M from a leading independent power producer in the south east of the US and a top Midwestern utility to provide SCR catalyst regeneration services. SCR-Tech will clean and regenerate catalysts from SCR systems located at coal-fired power plants operated by each customer. The process will extend the useful life of the existing catalyst, providing a lower cost alternative to purchasing new catalyst and eliminating the costs and environmental concerns associated with land filling spent catalyst. SCRTech offers a wide variety of services, including SCR catalyst cleaning, rejuvenation, and regeneration, as well as SCR system management and consulting services. Press release from: Catalytica Energy Systems Co, Charlotte, NC, USA. Website: http://www.CatalyticaEnergy.com (15 May 2007)
Shell Hydrogen to partner Virent Energy in developing hydrogen fuel Shell Hydrogen and Virent Energy Systems have entered into a five-year agreement to develop and commercialise Virent’s proprietary technology for making hydrogen from glycerol and sugar. Chemical Week, 30 May 2007, 169 (19), 4
JULY 2007